Literature DB >> 1458325

Principles of therapeutics.

T R Miller1.   

Abstract

Topical administration of drugs is the treatment of choice for diseases of the anterior segment. Drug levels attained by this means are usually of short duration, however, necessitating frequent therapy or continuous perfusion if prolonged drug levels are required. A drug-delivery device (collagen shield or contact lens) or subconjunctival injections can be used to augment topical therapy if frequent treatment is not possible. Subconjunctival injections are recommended for drugs that have low solubility and, hence, low corneal penetration. Retrobulbar injections are seldom indicated, except for regional anesthesia. Systemic administration is useful for anti-inflammatory therapy but it may be difficult to establish therapeutic levels of antibiotic agents in the eye because of the blood-ocular barrier. In severe cases, intraocular injection may be required.

Mesh:

Substances:

Year:  1992        PMID: 1458325     DOI: 10.1016/s0749-0739(17)30437-6

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  2 in total

1.  Deep subconjunctival injection of gentamicin for the treatment of bacterial conjunctivitis in macaques (Macaca mulatta and Macaca fascicularis).

Authors:  Sylvia I Gografe; Barbara C Hansen; Kenneth D Hansen
Journal:  Lab Anim (NY)       Date:  2015-03       Impact factor: 12.625

2.  The effects of local administration of mesenchymal stem cells on rat corneal allograft rejection.

Authors:  Zhe Jia; Fei Li; Xiaoyu Zeng; Ying Lv; Shaozhen Zhao
Journal:  BMC Ophthalmol       Date:  2018-06-08       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.